Advancing regulatory science for medical countermeasure development : workshop summary

Advancing regulatory science for medical countermeasure development : workshop summary /

Show other versions (1)

Whether or not the United States has safe and effective medical countermeasures--such as vaccines, drugs, and diagnostic tools--available for use during a disaster can mean the difference between life and death for many Americans. The Food and Drug Administration (FDA) and the scientific community a...

Full description

Saved in:
Bibliographic Details
Online Access: Full text (MCPHS users only)
Corporate Authors: Institute of Medicine (U.S.). Forum on Drug Discovery, Development, and Translation, Institute of Medicine (U.S.). Forum on Medical and Public Health Preparedness for Catastrophic Events
Other Authors: Wizemann, Theresa M., Altevogt, Bruce M., Claiborne, Anne B.
Format: Electronic eBook
Language:English
Published: Washington, D.C. : Natlional Academies Press, 2011
Subjects:
United States. > Food and Drug Administration > Congresses.
Emergency management > United States > Evaluation > Congresses.
Disaster medicine > United States > Evaluation > Congresses.
Weapons of mass destruction > Health aspects > Congresses.
Chemical agents (Munitions) > Congresses.
Disaster Planning > organization & administration
Emergency Medical Services > organization & administration
United States
Congress
proceedings (reports)
Conference papers and proceedings.
Local Note:ProQuest Ebook Central

Internet

Full text (MCPHS users only)

Similar Items